Get the Stockscreener App
42.55
0.09%
-0.04
After Hours:
42.55
Cerevel Therapeutics Holdings Inc Stock (CERE) Forecast
The Cerevel Therapeutics Holdings Inc (CERE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $51.68, representing a +21.47% increase from the current price of $42.55. The highest analyst price target is $54.99, and the lowest is $48.38.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CERE Price Target
Average 74.71
(+75.59% Upside)
Is Cerevel Therapeutics Holdings Inc (CERE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.90 | Neutral |
| STOCH(9,6) | 83.56 | Sell |
| STOCHRSI(14) | 83.46 | Sell |
| MACD(12,26) | 0.1608 | Buy |
| ADX(14) | 17.94 | Neutral |
| William %R | -19.47 | Sell |
| CCI(14) | 82.58 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
42.38
Buy
|
42.42
Buy
|
| MA20 |
42.15
Buy
|
42.28
Buy
|
| MA50 |
41.96
Buy
|
41.84
Buy
|
| MA100 |
41.99
Buy
|
39.88
Buy
|
| MA200 |
33.19
Buy
|
36.66
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CERE could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on CERE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.9 indicates that CERE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 83.56 indicates that CERE is oversold. This means that CERE price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 83.46 indicates that CERE is oversold. This suggests that CERE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.94 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 82.58 indicates that CERE is still overbought but not to an extreme extent.
Long-term CERE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cerevel Therapeutics Holdings Inc financial reports and earnings history, Cerevel Therapeutics Holdings Inc (CERE) stock could reach $187.64 by 2030, $579.26 by 2040 and $615.32 by 2050. See the projected annual prices until 2050 of the Cerevel Therapeutics Holdings Inc stock below:
- Cerevel Therapeutics Holdings Inc (CERE) is expected to reach an average price of $353.73 in 2035, with a high prediction of $354.15 and a low estimate of $338.57. This indicates an $731.33% rise from the last recorded price of $42.55.
- Cerevel Therapeutics Holdings Inc (CERE) stock is projected to chart a bullish course in 2040, with an average price target of $578.65, representing an $1,260% surge from its current level. The forecast ranges from a conservative $571.38 to a sky-high $579.26.
- Our analysts predict Cerevel Therapeutics Holdings Inc (CERE) to jump 764.78% by 2045, soaring from $351.46 to an average price of $367.96, potentially reaching $368.54. While $351.46 is the low estimate, the potential upside is significant.
- Cerevel Therapeutics Holdings Inc (CERE) stock is expected to climb by 2050, reaching an average of $611.94, a $1,338% jump from its current level. However, a wide range of estimates exists, with high and low targets of $615.32 and $600.40, respectively, highlighting the market's uncertainty.
Cerevel Therapeutics Holdings Inc Stock (CERE) Year by Year Forecast
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2024
Our forecast for CERE stock price in 2024 now indicates an average price target of $52.35 with a high forecast of $64.04 and a low forecast of $40.66. The average prediction reflects an increase of +23.03% from the last recorded price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $53.30 | $48.38 | $54.99 | +25.27% |
| July, 2024 | $52.36 | $52.30 | $55.20 | +23.06% |
| August, 2024 | $55.74 | $51.71 | $56.74 | +31.01% |
| September, 2024 | $59.96 | $54.69 | $60.66 | +40.93% |
| October, 2024 | $60.99 | $55.32 | $61.52 | +43.33% |
| November, 2024 | $60.98 | $59.35 | $62.06 | +43.31% |
| December, 2024 | $62.80 | $60.52 | $64.04 | +47.59% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2025
Cerevel Therapeutics Holdings Inc Stock (CERE) is expected to reach an average price of $87.87 in 2025, with a high prediction of $113.30 and a low estimate of $62.45. This indicates an +106.52% rise from the last recorded price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $75.46 | $62.45 | $82.04 | +77.34% |
| February, 2025 | $79.60 | $72.07 | $81.26 | +87.07% |
| March, 2025 | $87.71 | $77.35 | $88.29 | +106.14% |
| April, 2025 | $88.09 | $87.20 | $97.70 | +107.03% |
| May, 2025 | $100.99 | $87.58 | $101.04 | +137.35% |
| June, 2025 | $99.02 | $98.44 | $108.33 | +132.72% |
| July, 2025 | $96.82 | $92.49 | $99.95 | +127.56% |
| August, 2025 | $94.85 | $92.81 | $102.26 | +122.90% |
| September, 2025 | $96.03 | $89.84 | $97.14 | +125.68% |
| October, 2025 | $100.25 | $93.30 | $103.15 | +135.60% |
| November, 2025 | $108.92 | $100.18 | $110.04 | +155.98% |
| December, 2025 | $105.74 | $105.49 | $113.30 | +148.51% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2026
The predicted value for Cerevel Therapeutics Holdings Inc (CERE) in 2026 is set at an average of $116.78. Estimates vary from a peak of $136.21 to a trough of $97.34, indicating an +174.45% surge from the present price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $105.75 | $97.34 | $109.48 | +148.53% |
| February, 2026 | $104.46 | $102.64 | $109.49 | +145.50% |
| March, 2026 | $111.68 | $105.27 | $115.08 | +162.47% |
| April, 2026 | $119.99 | $108.51 | $126.59 | +182.01% |
| May, 2026 | $116.71 | $115.36 | $120.79 | +174.30% |
| June, 2026 | $117.48 | $114.17 | $120.79 | +176.09% |
| July, 2026 | $119.73 | $115.91 | $120.35 | +181.38% |
| August, 2026 | $122.32 | $117.20 | $123.77 | +187.47% |
| September, 2026 | $127.10 | $120.20 | $130.10 | +198.70% |
| October, 2026 | $131.24 | $125.97 | $132.36 | +208.44% |
| November, 2026 | $133.11 | $130.43 | $136.21 | +212.83% |
| December, 2026 | $127.74 | $126.47 | $135.04 | +200.22% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cerevel Therapeutics Holdings Inc (CERE) is $148.95, with a high forecast of $171.76 and a low forecast of $126.13. This indicates an +250.05% increase from the last price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $129.50 | $126.13 | $130.04 | +204.35% |
| February, 2027 | $139.58 | $129.32 | $140.00 | +228.05% |
| March, 2027 | $143.00 | $138.37 | $143.67 | +236.09% |
| April, 2027 | $143.46 | $142.49 | $146.63 | +237.15% |
| May, 2027 | $144.18 | $142.06 | $144.66 | +238.84% |
| June, 2027 | $139.15 | $135.73 | $145.43 | +227.02% |
| July, 2027 | $140.95 | $139.63 | $142.80 | +231.25% |
| August, 2027 | $142.71 | $138.77 | $145.11 | +235.39% |
| September, 2027 | $147.11 | $142.71 | $149.34 | +245.74% |
| October, 2027 | $150.93 | $146.90 | $151.08 | +254.72% |
| November, 2027 | $169.37 | $151.45 | $169.84 | +298.06% |
| December, 2027 | $171.42 | $169.57 | $171.76 | +302.88% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2028
In 2028, Cerevel Therapeutics Holdings Inc (CERE) is projected to reach an average price of $127.71, with a high projection of $180.55 and a low estimate of $74.87. This indicates an +200.14% rise from the last price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $172.44 | $171.78 | $174.64 | +305.28% |
| February, 2028 | $175.94 | $172.94 | $176.03 | +313.48% |
| March, 2028 | $178.37 | $176.21 | $178.39 | +319.19% |
| April, 2028 | $75.21 | $74.87 | $180.55 | +76.76% |
| May, 2028 | $85.70 | $76.20 | $86.67 | +101.42% |
| June, 2028 | $90.98 | $86.73 | $92.37 | +113.83% |
| July, 2028 | $91.30 | $90.56 | $92.89 | +114.56% |
| August, 2028 | $97.31 | $92.00 | $99.73 | +128.69% |
| September, 2028 | $101.34 | $97.56 | $104.53 | +138.17% |
| October, 2028 | $106.71 | $101.64 | $107.79 | +150.79% |
| November, 2028 | $109.91 | $106.93 | $111.54 | +158.32% |
| December, 2028 | $113.84 | $110.72 | $114.67 | +167.53% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2029
The 2029 price forecast for Cerevel Therapeutics Holdings Inc Stock (CERE) is $151.31 on average, with a high prediction of $188.23 and a low estimate of $114.40. This represents an +255.61% increase from the previous price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $130.65 | $114.40 | $132.99 | +207.05% |
| February, 2029 | $133.75 | $130.33 | $137.06 | +214.34% |
| March, 2029 | $150.94 | $134.87 | $151.43 | +254.74% |
| April, 2029 | $149.08 | $145.29 | $155.79 | +250.37% |
| May, 2029 | $167.94 | $148.34 | $169.12 | +294.68% |
| June, 2029 | $158.60 | $156.20 | $170.51 | +272.73% |
| July, 2029 | $166.43 | $158.39 | $166.50 | +291.14% |
| August, 2029 | $160.36 | $158.13 | $168.51 | +276.88% |
| September, 2029 | $164.67 | $161.14 | $172.12 | +287.01% |
| October, 2029 | $178.45 | $164.14 | $181.11 | +319.38% |
| November, 2029 | $184.76 | $176.20 | $188.23 | +334.21% |
| December, 2029 | $179.37 | $179.37 | $187.38 | +321.56% |
Cerevel Therapeutics Holdings Inc Stock (CERE) Price Forecast for 2030
Cerevel Therapeutics Holdings Inc Stock (CERE) is expected to reach an average price of $205.74 in 2030, with a high forecast of $236.66 and a low forecast of $174.82. This signifies an +383.52% surge from the last price of $42.55.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $186.88 | $174.82 | $187.64 | +339.21% |
| February, 2030 | $189.56 | $183.18 | $192.93 | +345.51% |
| March, 2030 | $193.93 | $190.03 | $197.67 | +355.76% |
| April, 2030 | $203.99 | $192.63 | $211.73 | +379.41% |
| May, 2030 | $204.75 | $202.03 | $208.48 | +381.20% |
| June, 2030 | $207.21 | $202.87 | $209.78 | +386.98% |
| July, 2030 | $214.94 | $206.65 | $215.46 | +405.16% |
| August, 2030 | $219.30 | $214.19 | $219.61 | +415.38% |
| September, 2030 | $225.28 | $216.05 | $226.46 | +429.44% |
| October, 2030 | $232.99 | $223.95 | $234.10 | +447.57% |
| November, 2030 | $228.30 | $227.93 | $236.66 | +436.54% |
| December, 2030 | $230.39 | $229.24 | $234.16 | +441.47% |
1.62%
0.15%
Cap:
|
Volume (24h):